Table 2.
Characteristics of the clinical trials found in PubMed by using the keywords: “tomato,” “platelet,” “antiplatelet,” and its compliance with EFSA requirements for anti-platelet effect health claim.
| References |
Type of tomato product |
Study performed on healthy subjects |
Duration of the study: 4 weeks of exposure (28 days) |
Analytical EFSA valid markers. |
|---|---|---|---|---|
| (20) | Tomato extract | NO (high-risk hypertensive patients) |
YES | NO |
| (22) | Tomato juice | NO | – | – |
| (23) | Tomato extract (2 different extract- supplemented treatment drinks) |
YES | NO | YES |
| (24) | Tomato extract (2 treatment supplement drinks using orange juice as a vehicle) |
YES | NO | YES |
| (12) | Water-soluble tomato extract, Fruitflow (FF) |
YES | YES | YES |
| (25) | Tomato pomace (byproduct of tomato pomace) extract (1 g, 2.5 g or placebo) |
YES (male, n = 99) |
NO | YES |
| (26) | Tomato extract Fruitflow® |
NO | NO | NO |